• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS, INC THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS, INC THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Lot Number D371-KIT
Device Problem Device Displays Incorrect Message (2591)
Patient Problem High Blood Pressure/ Hypertension (1908)
Event Type  malfunction  
Manufacturer Narrative
The system was used for treatment.A batch record review of kit lot d371 was conducted.There were no nonconformances associated with this lot.The lot met release requirements.The uvadex lot number was not provided as it was not administered.However, a review of all uvadex lots manufactured since january 2013 was performed.No trends or nonconformances related to the complaint were noted.Trends were reviewed for complaint categories, alarm #18: system pressure and pressure dome membrane leak.No trends were detected for these complaint categories.However, a corrective and preventive action (capa) was initiated for the investigation of pressure dome membrane leak and this capa is now closed.The assessment is based on information available at the time of the investigation.No product was returned for investigation; therefore, it could not be determined if the product met specification based solely on the information provided by the customer.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted through the capa/continuous improvement process.(b)(4).
 
Event Description
The customer reported that they received an alarm #18: system pressure alarm at 457 ml of whole blood processed (wbp).The customer stated that after the alarm#18: system pressure alarm occurred, there was a blood leak at the system pressure dome.The customer was advised to disconnect the patient from the kit and to flush the patient's catheter.The customer aborted the treatment with no blood returned to the patient.The customer stated that the patient's blood pressure was 131/80 after the aborted treatment and the patient's hematocrit was 40.4 before treatment.Thus, the patient's physician did not feel a blood transfusion was necessary at this time.The customer reported that the patient was in stable condition.The customer elected not to return the kit for investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERAKOS CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX
Manufacturer (Section D)
THERAKOS, INC
hampton NJ
Manufacturer (Section G)
HARMAC MEDICAL PRODUCTS
2201 bailey ave
buffalo NY 14211
Manufacturer Contact
megan vernak
53 frontage road
hampton, NJ 08827
MDR Report Key5605465
MDR Text Key44459284
Report Number2523595-2016-00111
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Nurse
Type of Report Initial
Report Date 03/28/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Nurse
Device Expiration Date12/01/2017
Device Lot NumberD371-KIT
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/28/2016
Initial Date FDA Received04/25/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/01/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Weight60
-
-